$0.7497
-0.02-2.00%
Pre-Market: 8:51 AM EDT
Comments
Loading...
CERo Therapeutics Hldgs Earnings Estimates, EPS & Revenue | NASDAQ:CERO | Benzinga
CERo Therapeutics Hldgs reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 19
EPS
$-9.000
Quarterly Revenue
$0.00
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of CERo Therapeutics Hldgs using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CERO | CERo Therapeutics Hldgs | -$18.00 | — | — | — | $0.00 | — | — | — | 05/16/2025 | Get Alert |
| CERO | CERo Therapeutics Hldgs | — | — | — | — | — | — | — | — | 04/08/2025 | Get Alert |
| CERO | CERo Therapeutics Hldgs | — | — | -$9.00 | — | — | — | $0.00 | — | 11/19/2024 | Get Alert |
| CERO | CERo Therapeutics Hldgs | — | — | -$15.00 | — | — | — | $0.00 | — | 08/14/2024 | Get Alert |
| CERO | CERo Therapeutics Hldgs | — | — | -$18.00 | — | — | — | $0.00 | — | 05/17/2024 | Get Alert |
CERo Therapeutics Hldgs (CERO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
CERo Therapeutics Hldgs (CERO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is CERo Therapeutics Hldgs (NASDAQ:CERO) reporting earnings?
CERo Therapeutics Hldgs (CERO) is scheduled to report earnings on May 16, 2025. The last reported earnings were for reported on November 19, 2024 for Q3.
What were the latest earnings per share (EPS) for CERo Therapeutics Hldgs (NASDAQ:CERO)?
The Actual EPS was $-9.00, which missed the estimate of $0.00.
What were CERo Therapeutics Hldgs’s (NASDAQ:CERO) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.